SEC Tracker
Get the app

Vogenx VOGX

Vogenx appoints Richard Gorman as Chief Commercial Officer

Form
8-K
Filed
Importance
Major
  1. Resigned from Board on Oct 12, 2026
  2. Joined as Chief Commercial Officer on Oct 12, 2026
  3. Previously served on Board since 2022

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Vogenx files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX